TWD 37.1
(-2.5%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 233.97 Million TWD | 20.49% |
2022 | 194.17 Million TWD | 23.77% |
2021 | 156.88 Million TWD | 13.16% |
2020 | 138.63 Million TWD | 22.24% |
2019 | 113.41 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 272.47 Million TWD | 16.46% |
2024 Q2 | 272.47 Million TWD | 0.0% |
2023 Q2 | 201.39 Million TWD | 0.0% |
2023 FY | 233.97 Million TWD | 20.49% |
2023 Q4 | 233.97 Million TWD | 0.0% |
2023 Q3 | 233.97 Million TWD | 16.18% |
2023 Q1 | 201.39 Million TWD | 3.72% |
2022 Q4 | 194.17 Million TWD | 0.0% |
2022 Q3 | 194.17 Million TWD | 0.0% |
2022 FY | 194.17 Million TWD | 23.77% |
2021 FY | 156.88 Million TWD | 13.16% |
2020 FY | 138.63 Million TWD | 22.24% |
2019 FY | - TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 61.1% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | -50.528% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -454.817% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 78.651% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 85.361% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 78.648% |
Center Laboratories, Inc. | 269.22 Million TWD | 13.095% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -208.686% |
InnoPharmax Inc. | 22.24 Million TWD | -951.89% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | -68.559% |
Excelsior Biopharma Inc. | 217.28 Million TWD | -7.682% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -142.42% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | -84.522% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -708.361% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 17.575% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | -102.16% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -2222.533% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -318.181% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | -97.62% |